NIH's Role In Sustaining the U.S. Economy 2021 Update Now Available here
UMR Urges House and Senate Leaders to Include NIH Funding in COVID Relief Package read here
UMR releases new fact sheets on COVID-19 and biomedical research. Read here
See how UMR members are aiding in the fight against the coronavirus here
A new episode of the Amazing Things Podcast is now available! Check it out here.

A participant in the NIH 2019-2020 Medical Research Scholars Program.

Photo Credit: National Institutes of Health

About This Photo

Northwestern spinoff receives $21.3M from NIH to manufacture COVID-19 test

A new, highly sensitive, easy-to-use test for COVID-19 that requires a single swab and 15 minutes has received $21.3 million from the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADxSM) initiative. Developed at Northwestern University’s Center for Innovation in Global Health Technologies (CIGHT), the point-of-care technology is being commercialized by Northwestern spinoff company Minute Molecular Diagnostics, which will use the NIH grant to ramp up production to one million test cartridges per month.